February 13, 2024 Comments Off on New patent for Abbvie drug NAMZARIC Posted in: Patent Added Annual Drug Patent Expirations for NAMZARIC Namzaric is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent for Abbvie drug NAMZARIC appeared first on DrugPat…
February 13, 2024 Comments Off on Drug Patent Expirations for the Week of February 11, 2024 Posted in: Uncategorized
OSPHENA (ospemifene) Duchesnay Patent: 9,855,224 Expiration: Feb 13, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…
